Trademark Overview
On Friday, December 22, 2023, a trademark application was filed for EFESA with the United States Patent and Trademark Office. The USPTO has given the EFESA trademark a serial number of 79391354. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Thursday, August 8, 2024. This trademark is owned by Genexine, Inc.. The EFESA trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceutical preparations for the treatment of diseases of the endocrine system; pharmaceutical agents affecting metabolism; cardiovascular treatment preparations; cardiovascular pharmaceutical preparations; pharmaceutical preparations for the treatment of kidney disorders; pharmaceutical preparations for the treatment of kidney diseases; pharmaceutical preparations for the treatment of diseases of the metabolic system; pharmaceutical preparations for the treatment of cardiovascular disease; medicines for the treatment of cardiovascular and cerebrovascular diseases; pills for dizziness symptoms treatment; biological preparations for medical purposes; cardiovascular agents for medical purposes; drugs for medical purposes; synthetic peptides for pharmaceutical purposes; pharmaceuticals; medicines for human purposes; anemia treatment medicines that stimulate red blood cell production; medicines to stimulate red blood cell production; medicines for treatment of chronic kidney disease and...
